[go: up one dir, main page]

CA3044735A1 - Formations de cannabinoides hydrosolubles comprenant une enzyme - Google Patents

Formations de cannabinoides hydrosolubles comprenant une enzyme Download PDF

Info

Publication number
CA3044735A1
CA3044735A1 CA3044735A CA3044735A CA3044735A1 CA 3044735 A1 CA3044735 A1 CA 3044735A1 CA 3044735 A CA3044735 A CA 3044735A CA 3044735 A CA3044735 A CA 3044735A CA 3044735 A1 CA3044735 A1 CA 3044735A1
Authority
CA
Canada
Prior art keywords
formulation
acid
lipase
agent
detergent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA3044735A
Other languages
English (en)
Other versions
CA3044735C (fr
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA3044735A priority Critical patent/CA3044735C/fr
Publication of CA3044735A1 publication Critical patent/CA3044735A1/fr
Application granted granted Critical
Publication of CA3044735C publication Critical patent/CA3044735C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3044735A 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme Active CA3044735C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3044735A CA3044735C (fr) 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3044735A CA3044735C (fr) 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme

Publications (2)

Publication Number Publication Date
CA3044735A1 true CA3044735A1 (fr) 2019-08-07
CA3044735C CA3044735C (fr) 2021-01-19

Family

ID=67542473

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3044735A Active CA3044735C (fr) 2019-05-30 2019-05-30 Formations de cannabinoides hydrosolubles comprenant une enzyme

Country Status (1)

Country Link
CA (1) CA3044735C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114073671A (zh) * 2020-08-14 2022-02-22 中国科学院化学研究所 一种大麻二酚水溶性组合物、制剂及其制备方法和应用
LU102018B1 (de) * 2020-08-26 2022-02-28 K D Pharma Bexbach Gmbh Extraktionsverfahren und Stoffgemisch
WO2022043422A1 (fr) * 2020-08-26 2022-03-03 K.D. Pharma Bexbach Gmbh Procédé d'extraction et mélange
US11992497B2 (en) 2021-08-04 2024-05-28 Demeetra Agbio, Inc. Cannabinoid derivatives and their use

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114073671A (zh) * 2020-08-14 2022-02-22 中国科学院化学研究所 一种大麻二酚水溶性组合物、制剂及其制备方法和应用
LU102018B1 (de) * 2020-08-26 2022-02-28 K D Pharma Bexbach Gmbh Extraktionsverfahren und Stoffgemisch
WO2022043422A1 (fr) * 2020-08-26 2022-03-03 K.D. Pharma Bexbach Gmbh Procédé d'extraction et mélange
US11992497B2 (en) 2021-08-04 2024-05-28 Demeetra Agbio, Inc. Cannabinoid derivatives and their use
US12433903B2 (en) 2021-08-04 2025-10-07 Demeetra Agbio, Inc. Cannabinoid derivatives and their use

Also Published As

Publication number Publication date
CA3044735C (fr) 2021-01-19

Similar Documents

Publication Publication Date Title
US11298336B2 (en) Water soluble formulation
CA3044735C (fr) Formations de cannabinoides hydrosolubles comprenant une enzyme
EP2040672B1 (fr) Compositions liquides de phényléphrine à stabilité améliorée
US9744133B2 (en) Enhanced stability of novel liquid compositions
US20170252300A1 (en) Orally administrable composition
JP2019525963A (ja) 新規経口投与製剤
WO2005115353A1 (fr) Suspension pharmaceutique
HU227452B1 (en) Mucoadhesive pharmaceutical formulation
JP2002534463A (ja) 改善された薬剤活性体投与性をもつ組成物
US20250360176A1 (en) Chewing gum containing synergistic medicinal compounds
CA3087742C (fr) Forme pharmaceutique sur film
JP2006515603A (ja) 粉末医薬組成物
WO2016084099A1 (fr) Composition de capsule en gélatine souple d'agents antitussifs
EP0228223A2 (fr) Solution non irritante à base de suprofène
JP2006089415A (ja) カフェイン含有カプセル製剤
CA3175841A1 (fr) Formulations naturellement derivees, a administration orale, contenant des emulsions de phytocannabinoide
US20240156844A1 (en) Orally administrable formulation
JP2025542098A (ja) 経口投与可能な製剤
MX2007010163A (es) Composicion farmaceutica liquida acuosa estable a temperatura ambiente.
EP4279062A1 (fr) Composition liquide et son utilisation, procédé de traitement et kit
WO2005032516A1 (fr) Formulation et procede de fabrication de capsules d'aceclofenac auto-microemulsionne
RS53364B (sr) Stabilna tečna farmaceutska formulacija